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Abstract Cox15p is essential for the biogenesis of cytochrome
oxidase [Glerum et al., J. Biol. Chem. 272 (1997) 19088^19094].
We show here that cox15 mutants are blocked in heme A but not
heme O biosynthesis. In Schizosaccharomyces pombe COX15 is
fused to YAH1, the yeast gene for mitochondrial ferredoxin
(adrenodoxin). A fusion of Cox15p and Yah1p in Saccharomyces
cerevisiae rescued both cox15 and yah1 null mutants. This
suggests that Yah1p functions in concert with Cox15p. We
propose that Cox15p functions together with Yah1p and its
putative reductase (Arh1p) in the hydroxylation of heme
O. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The COX15 gene of Saccharomyces cerevisiae was previ-
ously shown to be essential for expression of functional cyto-
chrome oxidase [1]. Mutations in this gene, as in other nuclear
genes that function in cytochrome oxidase assembly, lead to
the loss of the visible absorption bands of cytochromes a and
a3, and promote increased turnover of the mitochondrial
translated subunits of cytochrome oxidase. Cox15p is an in-
trinsic membrane protein with seven putative transmembrane
domains. It is a low abundance protein of the mitochondrial
inner membrane. Cox15p has homologs in fungal (GenBank
accession number AF079448), mammalian [2], £y (GenBank
accession number AE003462), and worm genomes (GenBank
accession number Z49130). In Schizosaccharomyces pombe,
COX15 is fused to YAH1 encoding mitochondrial ferredoxin
(unpublished observation). Despite their marginal sequence
similarity, the ctaA gene product of Bacillus [3] and other
related bacterial proteins may also be homologs of mitochon-
drial Cox15p.
To learn more about the function of Cox15p, an improved
method for separation of hemes A and O by HPLC was used
to screen cytochrome oxidase mutants for their mitochondrial
content of hemes. Only two mutants were found to lack heme
A. One of the mutants had a mutation in COX10, which is
known to encode heme A:farnesyl transferase that catalyzes
the farnesylation of protoheme to heme O [4]. This mutant
lacks both hemes A and O. The second heme A de¢cient
mutant had a mutation in COX15. Unlike the cox10 mutant,
however, the cox15 mutant displayed the presence of heme O.
This phenotype is expected in a mutant blocked in the last
step of heme A biosynthesis in which the methyl at position 8
of the porphyrin ring is converted to a formyl group. We
propose that Cox15p is a monooxygenase which in conjunc-
tion with mitochondrial ferredoxin and ferredoxin reductase
catalyzes the oxidation of the methyl to the corresponding
alcohol.
2. Materials and methods
2.1. Yeast strains and media
The genotypes and sources of the strains of S. cerevisiae used in this
study are listed in Table 1. The compositions of YPD (rich glucose),
YEPG (rich glycerol), and YPGal (rich galactose) used to grow yeast
have been described elsewhere [5].
2.2. Extraction and separation of mitochondrial hemes
Mitochondria, prepared as described previously [5], were suspended
in 0.5 M sorbitol, 20 mM Tris^HCl, pH 7.5, 0.5 mM EDTA at a
protein concentration of 15^20 mg/ml. Total heme was extracted from
3 mg of mitochondrial protein with 1 ml of acetone containing 2.5%
HCl. The mixture was vortexed, clari¢ed by centrifugation and mixed
with an equal volume of 50% acetonitrile. Insoluble material was
removed by a second centrifugation. The extract was adjusted to
approximately pH 3.5 with 1.65 M ammonium hydroxide, clari¢ed
by centrifugation, and applied to a 3.9U300 mm C18 Bondclone
column (Phenomenex, CA, USA). Hemes were eluted at a £ow rate
of 1 ml/min using a 30^50% acetonitrile gradient over the ¢rst 5 ml,
followed by a 50^75% linear acetonitrile gradient over the subsequent
35 ml. The acetonitrile solutions contained 0.05% tri£uoroacetic acid.
The elution of heme compounds was monitored at 400 nm. The elu-
tion times are a¡ected by the pH of the sample applied to the column.
2.3. Construction of a COX15^YAH1 fusion gene
YAH1 was copied from yeast nuclear DNA by polymerase chain
reaction (PCR) with primers: 5P-ggcaagcttgggggcacaaatgaggg and 5P-
ggcggatccatgcatccttttacgcacctct. The 0.5 kb product was digested with
BamHI and HindIII and ligated to pUC18. The COX15 region was
obtained by ampli¢cation of the gene in plasmid pG4/T1 [1] with
primers 5P-agattccaaggatccacgatcgct and 5P-ggcatgcatggtaatgat-
tacgtttctc. This 1.67 kb fragment was digested with NsiI and BamHI
and ligated to the pUC18 construct with YAH. The fusion gene was
transferred to the multicopy plasmids YEp352 (pYAH/ST8) and
YEp351 (pYAH/ST9) and to the integrative plasmids YIp352
(pYAH/ST11) and YIp351 (pYAH/ST10) [6]. The one-step gene in-
sertion method of Rothstein [7] was used to integrate the gene at the
LEU2 or URA3 loci of yeast chromosomal DNA.
2.4. Miscellaneous procedures
Proteins were separated by PAGE in the bu¡er system of Laemmli
[8]. Yah1p and Cox15p^Yah1p were visualized on Western blots with
antibody against a short synthetic peptide with a Yah1p sequence [9]
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followed by a secondary reaction with 125I-protein A or with the
Super Signal detection system (Pierce, Rockford, IL, USA).
3. Results and discussion
3.1. Heme A is absent in a cox15 null mutant
Cytochrome oxidase de¢ciency is one of the more common
phenotypes encountered among nuclear pet mutants of S. ce-
revisiae. The collection that we have been studying contains at
least three dozen complementation groups whose members
display the absence of cytochrome oxidase, by both enzymatic
and spectral criteria [10]. Approximately, a third of the genes
de¢ned by these mutants encode proteins that a¡ect cyto-
chrome oxidase at late stages of its assembly and include
mutants that are defective in heme A biosynthesis [4] and
copper homeostasis [11,12].
Improved conditions for the separation of heme compo-
nents by reverse phase HPLC have allowed us to more accu-
rately gauge the heme composition of mitochondria from cy-
tochrome oxidase de¢cient mutants and to correct an earlier
mistaken impression that the cox15 mutant contained low but
detectable amounts of heme A [1]. In the present study we
have screened mutants from 13 di¡erent complementation
groups including strains with lesions in structural subunits
(subunits 4, 5, and 6) and in nuclear gene products required
for cytochrome oxidase assembly. In 12 mutants the heme A
was reduced to 4^12% of the wild type strain while the heme
O concentration was increased by a factor of 2^8. These ef-
fects on the two hemes are illustrated by the chromatogram
obtained with the sco1 mutant (Fig. 1). A b‡ mutant which is
unable to synthesize cytochrome oxidase because of a com-
plete loss of its mitochondrial genome also had reduced
amounts of hemes A and O. The two exceptions were the
cox10 and cox15 mutants, both of which lacked heme A. In
agreement with earlier results the cox10 mutant also had no
heme O [4]. This was not true of the cox15 mutant which had
a very low but detectable amount of heme O (Fig. 1). The
absence of heme A but not heme O in the cox15 null mutant
suggests that Cox15p is involved in some aspect of the con-
version of heme O to heme A.
A mutational block preventing hydroxylation of the methyl
group in heme O as suggested here for the cox15 mutant
should result in an increased content of mitochondrial heme
O. The fact that this is not observed suggests that for reasons
we do not understand at present, the heme O intermediate is
more unstable in the cox15 than in other cytochrome oxidase
mutants. As indicated above, the amount of heme O detected
in the other mutants varied over a four-fold range indicating
that the stability of this intermediate might depend on other
factors. This is also true of the ¢nal heme A product. For
example, all the mutant examined displayed signi¢cant reduc-
tions in heme A. This was also true of the b‡ strain (Fig. 1) in
which heme A biosynthesis should not be a¡ected.
3.2. Fusion of COX15 and YAH1
Protein homology searches revealed that COX15 of
Schizosaccharomyces pombe is fused at its 3P end to another
gene homologous to YAH1. The product of YAH1 has been
shown in S. cerevisiae to encode mitochondrial ferredoxin [9].
The fusion of the two genes implies that Cox15p and ferre-
doxin (Yah1p) function in a common pathway. To test
whether a single protein expressed from the two S. cerevisiae
genes would also be functional, COX15 and YAH1 were fused
so as to create a continuous reading frame homologous to the
naturally occurring gene of S. pombe (Fig. 2A). This construct
lacked the sequences encoding the 24 C-terminal residues of
Cox15p and the ¢rst 19 residues of Yah1p. The N-terminal
sequence of Yah1p probably functions as a mitochondrial
targeting signal. In addition the fusion protein had a methio-
nine at the junction of Cox15p and Yah1p which does not
occur in either protein.
The S. cerevisiae fusion gene was introduced into a
cox15 null mutant both on a multicopy episomal plasmid
(pYAH/ST8) and in single copy (pYAH/ST11) by integration
into chromosomal DNA. In both instances the respiratory
defect of the mutant was complemented and the transform-
ants were able to grow as well as the wild type parental strain
on non-fermentable carbon sources (Fig. 2B). Since the null
mutation in YAH1 is lethal [9], the transformations with the
fusion gene in the episomal and integrative plasmids were
done with a heterozygous diploid strain containing only one
copy of the yah1 null allele. The transformants were sporu-
lated and analyzed by tetrad dissections. This analysis showed
that meiotic spore progeny with the yah1 null allele were
viable in the presence of the fusion gene and displayed wild
type growth properties even when the gene was present in
single copy. These results indicate that the functions of the
S. cerevisiae Cox15p and Yah1p proteins are not compro-
mised when they are incorporated into a single polypeptide
modeled on the native protein of S. pombe.
Both transformants with the multicopy and integrated
fusion gene had a mitochondrial protein estimated by
SDS^PAGE to be approximately 67 kDa, a value in good
agreement with the mass of 69 248 Da expected for the pri-
Table 1
Genotypes and sources of S. cerevisiae strains
Strain Genotype Source
W303-1A a ade2-1 his3-15 leu2-3,115 trp1-1 ura3-1 R. Rothstein, Department of
Human Genetics and
Development, Columbia University
W303b‡ K ade2-1 his3-15 leu2-3,115 trp1-1 ura3-1b‡
aW303vCOX15 a ade2-1 his3-15 leu2-3,115 trp1-1 ura3-1 cox15: :HIS3 [1]
aW303vCOX15/ST10 a ade2-1 his3-15 leu2-3,115 trp1-1 ura3-1 cox15: :HIS3 leu2: :pYAH/ST10 This study
a/KW303vYAH1 a/K ade2-1/ade2-1 his3-15/his3-15 leu2-3,115/leu2-3,115 trp1-1/trp1-1
ura3-1/ura3-1 yah1: :URA3/YAH1
[9]
W303vCOX15,YAH1/ST10 K ade2-1 his3-15 leu2-3,115 trp1-1 ura3-1 cox15: :HIS3 yah1: :URA3
leu2: :pYAH/ST10
This study
W303vYAH1/ST1 a ade2-1 his3-15 leu2-3,115 trp1-1 ura3-1 yah: :URA3 plus pYAH1/ST1 [9]
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mary product expressed from the fusion gene (Fig. 2C). The
small di¡erence between the predicted and measured sizes
could be due to loss of an N-terminal presequence in
Cox15p. The identity of the 67 kDa band as the hybrid pro-
tein was supported by its higher concentration in mitochon-
dria of cells transformed with the multicopy plasmid. These
results provide strong evidence that complementation of the
cox15 and yah1 mutants was e¡ected by the hybrid protein
rather than by a proteolytic product that might be derived
from it.
3.3. Is Cox15p a monooxygenase?
The oxidation of the methyl group at position 8 of the
porphyrin ring in heme O to a formyl group requires an initial
hydroxylation of the methyl to the corresponding alcohol,
followed by the further oxidation of the alcohol to the alde-
hyde. The initial hydroxylation reaction must be catalyzed by
a monooxygenase while the ¢nal oxidation step involves a
dehydrogenation.
The presence of a single COX15^YAH1 gene in S. pombe
and the demonstration that a similar fusion in S. cerevisiae is
Fig. 1. Analysis of mitochondrial hemes in wild type and mutant mitochondria. Mitochondria (3 mg) of the wild type strain W303-1A, of
aW303vCOX15 (cox15 null mutant), aW303vSCO1 (sco1 null mutant), and aW303b‡ (a b‡ derivative of W303-1A) were extracted with acidic
acetone and separated by reverse phase chromatography. The protoheme, heme A, and heme O peaks were identi¢ed from the elution times of
known standards. The peak eluting at 25 min has not been identi¢ed. It is unlikely to be related to heme A since it is present in a cox10 null
mutant that is blocked in farnesylation of protoheme (data not shown). The areas under the protoheme, heme A, and heme O peaks were
quantitated and are reported in arbitrary units between the parentheses.
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able to complement mutations in the respective genes suggest
that the two proteins function in a common step or pathway.
The absence of heme A (but not heme O) in a cox15 mutant
indicates that Cox15p, and by inference Yah1p, catalyzes ei-
ther the hydroxylation or the dehydrogenation step in the
pathway. We propose that the two proteins are part of a
mitochondrial (prokaryotic) type monooxygenase that hy-
droxylates the methyl group of heme O. Accordingly, the
third component of this pathway is ferredoxin (adrenodoxin)
dehydrogenase encoded by ARH1 which has been localized in
mitochondria of S. cerevisiae [13]. As depicted in Fig. 3, the
function of Cox15p would be analogous to that of P450 in
other three component monooxygenases [14].
3.4. Is Cox15p homologous to the bacterial ctaA product?
The ctaA product of Bacillus subtilis has been implicated in
the hydroxylation or dehydrogenation of heme O [15]. Mu-
tants in ctaA have been shown to contain heme O but not
heme A [15]. Furthermore, Escherichia coli transformed with
the B. subtilis ctaA gene converts heme O to heme A which is
normally absent in this organism [3]. The product of ctaA has
been shown to contain 0.2 mol of protoheme per mol of
protein [16]. The substoichiometric amount of protoheme,
however, could be a consequence of the fact that the protein
was obtained from an overexpressing strain. When ctaB, en-
coding protoheme farnesyl transferase, and ctaA were both
overexpressed, CtaA was found to contain equimolar
amounts of protoheme and heme A [16]. The protoheme
was suggested to be a prosthetic group of the enzyme involved
in hydroxylation while the heme A was the product formed in
the reaction. These ¢ndings suggested that in analogy to P450
in three component monooxygenases, CtaA is most likely in-
volved in the reduction of molecular oxygen for the hydrox-
ylation reaction [16].
An alignment of Cox15p with the ctaA products of B. sub-
tilis and Staphylococcus aureus shows a very low but sugges-
tive sequence similarity of the three proteins (Fig. 4). The
bacterial proteins are shorter, lacking some 80 N-terminal
residues and several shorter internal sequences that are
present in Cox15p (Fig. 3). Despite this size di¡erence,
Cox15p and CtaA both have seven putative transmembrane
domains (not shown). Taken together, the similarities in the
primary sequence and domain structure suggest that the mi-
tochondrial and present-day bacterial heme O monooxyge-
nases are evolutionarily related but have undergone substan-
tial divergence.
We were unsuccessful in detecting any sequence similarity
between Cox15p and P450. The protoheme prosthetic group
of bacterial, mitochondrial, and microsomal P450s is coordi-
nated to the sulfur of cysteine [17]. There are three cysteines in
the yeast Cox15p but none is conserved in either the mito-
chondrial or bacterial CtaA homologs. This is also true of the
methionine residues. Three histidines (His-167, -243, and
-366), however, are conserved among all the mitochondrial
and bacterial proteins and therefore are the most likely can-
didates to be ligands for protoheme.
According to its proposed function in heme O hydroxyla-
tion, Cox15p catalyzes a reaction analogous to the reduction
of molecular oxygen by P450. The lack of any sequence sim-
ilarity between the two proteins suggests that Cox15p may be
a novel type of heme monooxygenase.
Two plasmid constructs containing hybrid COX15/CtaA
failed to rescue the respiratory defect of the cox15 mutant.
Similarly, E. coli harboring the yeast COX15^YAH1 fusion
gene did not produce detectable heme A. The inability
of the yeast genes to convert heme O to heme A in E. coli
and of the Bacillus ctaA gene to complement the yeast mutant
is not too surprising in view of earlier ¢ndings that the human
mitochondrial Cox15p, ferredoxin, and ferredoxin reduc-
Fig. 2. Properties of yeast transformed with the COX15^YAH1 fu-
sion gene. A: Complementation of cox15 and yah1 null mutants by
the COX15^YAH1 fusion. The following strains were streaked on
YPD medium, replicated on rich glycerol medium, and incubated
overnight at 30‡: W303-1A, parental wild type strain; aW303-
vYAH1/ST9 (vYAH1/ST9), the yah1 null mutant transformed with
a multicopy plasmid containing COX15-YAH1 ; aW303vYAH1/
ST10 (vYAH1/ST10), the yah1 null mutant with a single integrated
copy of COX15^YAH1 ; W303vCOX15,YAH1/ST10, the cox15,yah1
double null mutant with a single chromosomally integrated copy of
COX15^YAH1. B: Expression of the fusion protein in mutant
strains harboring COX15^YAH1 either on a multicopy plasmid or
integrated into chromosomal DNA. Mitochondria (20 Wg protein)
were prepared from the indicated strains and were separated by
PAGE on a 12% polyacrylamide gel. Proteins were transferred to
nitrocellulose and probed with an antibody against Yah1p. aW303-
vYAH1/ST1 (vYAH1/ST1) is the yah1 null mutant transformed
with YAH1 on a multicopy plasmid and aW303vCOX15/ST9
(vCOX15/ST9) is a cox15 null mutant with a chromosomally inte-
grated copy of COX15^YAH1.
Fig. 3. Scheme showing reactions catalyzed by Arh1p, Yah1p, and
Cox15p in hydroxylation of the methyl group in heme O. nHFe re-
fers to the non-heme iron of ferredoxin and HFe to heme iron of
Cox15p.
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tase are not interchangeable with the yeast proteins even
though they share extensive sequence similarity (Glerum, per-
sonal observation; [8,9]). This apparently does not apply to
bacteria where the Bacillus monooxygenase when introduced
into E. coli is able to convert endogenous heme O to heme A
[3].
3.5. Localization of Yah1p and Cox15^Yah1p
Cox15p was previously localized in the mitochondrial inner
membrane but its topology was not determined [1]. Yah1p, on
the other hand, is a soluble matrix protein (Fig. 5A) [9]. The
Cox15^Yah1p fusion protein is an integral membrane protein
with properties similar to Cox15p (data not shown). It is
Fig. 4. Alignment of Cox15p with the ctaA products of B. subtilis and S. aureus. The alignment shows identical residues (darkened) and conser-
vative substitutions (shadowed) shared by all three proteins.
Fig. 5. Localization of Yah1p and the Cox15^Yah1p fusion protein. Mitochondria prepared by the method of Glick and Pon [20] were sus-
pended at a protein concentration of 7 mg/ml and diluted either with seven volumes of 0.6 M sorbitol, 10 mM HEPES, pH 7.5 or with seven
volumes of 10 mM HEPES, pH 7.5 bu¡er to rupture the outer membrane. To one half of each sample was added proteinase K at a ¢nal con-
centration of 40 Wg/ml. After incubation at 4‡C for 30 min, the mitochondria (Mit) and mitoplasts (Mtp) were collected by centrifugation,
washed with 5% trichloroacetic acid and separated by PAGE on a 12% polyacrylamide gel. Proteins were transferred to nitrocellulose and re-
acted with antibody against Yah1p (upper panels) and separately against the intermembrane marker cytochrome b2 (Cyt b2, lower panels). The
higher molecular weight protein detected by the Yah1p antibody in the mitochondrial fraction is probably some Yah1p precursor that accumu-
lates in the intermembrane space. It is protected against proteinase K in mitochondria and is lost during the conversion of mitochondria to mi-
toplasts. A: Mitochondria were prepared from the wild type strain W303-1A. B: Mitochondria from W303vCOX15,YAH1/ST10, a double mu-
tant with null mutations in cox15 and yah1 and harboring a chromosomally integrated copy of COX15^YAH1.
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present in the mitoplast fraction obtained by hypotonic swell-
ing of mitochondria and is clipped by proteinase K to two
smaller fragments (Fig. 5B). Since the antibody used in these
experiments recognizes the Yah1p component, the proteinase-
sensitive sites must be located in the Cox15p parts of the
hybrid protein that are exposed to the intermembrane space.
These results further indicate that the C-terminal end of
Cox15p, together with Yah1p, is located in the matrix com-
partment. Yah1p fused to Cox15p is therefore in the same
compartment as the native protein (Fig. 5B).
In addition to its proposed function in heme A synthesis,
Yah1p has been shown to participate in biogenesis of the
iron^sulfur cluster prosthetic groups of mitochondrial and
cytoplasmic proteins [18,19]. Expression of Yah1p as part of
a larger fusion protein did not a¡ect the growth properties of
S. cerevisiae on either fermentable or non-fermentable sub-
strates indicating that it is able to support iron^sulfur cluster
formation. Yah1p can therefore function with equal e⁄ciency
both as a peripheral component of the inner membrane and as
a soluble matrix protein in both heme A synthesis and iron^
sulfur cluster formation. The Arh1p (ferredoxin reductase) is
tightly associated with the mitochondrial inner membrane
even though it has no recognizable transmembrane domains
[13]. It is possible that there is a further association of Arh1p
with the Cox15^Yah1p fusion protein in the membrane that
may be necessary for the functions of Yah1p in both the heme
A and iron^sulfur cluster synthesis pathways.
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